Selective Targeting of Multiple Myeloma Cells with a Monoclonal Antibody Recognizing the Ubiquitous Protein CD98 Heavy Chain

Scientists reported that multiple myeloma (MM), an incurable hematological malignancy, could be specifically targeted by a monoclonal antibody that recognized a ubiquitously present protein, CD98 heavy chain.